2019
DOI: 10.1177/1753425918806363
|View full text |Cite
|
Sign up to set email alerts
|

Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia

Abstract: Neisseria meningitidis infections in sub-Saharan Africa usually present with distinct symptoms of meningitis but very rarely as fulminant septicemia when reaching hospitals. In Europe, development of persistent meningococcal shock and multiple organ failure occurs in up to 30% of patients and is associated with a bacterial load of >106/ml plasma or serum. We have prospectively studied 27 Ethiopian patients with meningococcal infection as diagnosed and quantified with real-time PCR in the cerebrospinal fluid (C… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 44 publications
0
9
0
Order By: Relevance
“…The overall incidence of meningitis has declined in recent decades due to the increasing use of meningococcal vaccines,[ 5 ] but the incidence of meningitis from bacterial strains not covered by vaccines has increased, and bacterial meningitis remains a significant public health problem. About 200,000 patients worldwide die from bacterial meningitis every year, and the mortality can be up to 60% in parts of sub-Saharan Africa and in poor and developing countrie s[ 6 , 7 ]. Patients who receive treatment have a mortality rate of about 10%, but survivors often experience serious sequelae, including limb amputation, neurological deficits, and other serious disabilitie s[ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…The overall incidence of meningitis has declined in recent decades due to the increasing use of meningococcal vaccines,[ 5 ] but the incidence of meningitis from bacterial strains not covered by vaccines has increased, and bacterial meningitis remains a significant public health problem. About 200,000 patients worldwide die from bacterial meningitis every year, and the mortality can be up to 60% in parts of sub-Saharan Africa and in poor and developing countrie s[ 6 , 7 ]. Patients who receive treatment have a mortality rate of about 10%, but survivors often experience serious sequelae, including limb amputation, neurological deficits, and other serious disabilitie s[ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Accordingly, 144 (43%) women and 188 (57%) men were included though the distribution varied between the different age groups (Table 1). The median ages of patients and healthy controls were 35 (IQR: 25-45) years and 25 (22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32) years, respectively. The age and gender distribution of patients included in the present study is shown in Table 1.…”
Section: Sociodemographic and Clinical Characteristicsmentioning
confidence: 99%
“…Recently, studies had reported that a variety of in ammatory factors were highly expressed in the cerebrospinal uid of patients with S. pneumoniae meningitis, including TNF-α, IL-6, IL-4 and IL-1β [4]. Yau found that TNF-α is an early in ammatory factor and can destroy the blood-brain barrier, then the plasma proteins could enter the brain tissue to aggravate brain damage [1].…”
Section: Introductionmentioning
confidence: 99%